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The risk of osteoporosis or osteopenia is known to
increase after childhood cancer treatment. The purpose
of this study was to evaluate patterns of bone mineral
density (BMD) and factors related to decreased BMD in
childhood cancer survivors.
We studied 78 patients (34 males, 44 females) treated
for acute lymphoblastic leukemia, acute myelogenous
leukemia or chronic myelogenous leukemia during
childhood. Clinical data, laboratory finding, bone age,
lumbar BMD (LBMD) and femur neck BMD (FNBMD)
were investigated. Chronological age at evaluation was
11.6±3.4 yr in males and 13.0±3.3 yr in females. Primary
disease, chronological age at treatment, body mass index
(BMI), method of treatment (chemotherapy, radiotherapy),
endocrine function, presence of chronic graft-versus-host
disease (cGVHD) and relevance of BMD standard devia-
tion score (SDS) were evaluated. LBMD and FNBMD of
the subjects were -0.91±1.41 and -1.13±1.79, respectively.
Twenty (25.7%) patients had LBMD SDS lower than -2.
Nineteen (24.4%) patients had FNBMD SDS lower than
-2. The patients treated with hematopoietic stem cell
transplantation had lower LBMD SDS (-1.17±1.39 vs -0.43
±1.33, P=0.025). The risk of having LBMD SDS <-2 was
higher in the patients treated with glucocorticoid for
cGVHD (36.6% vs 13.5%; odds ratio [OR], 3.7; P=0.020).
In multivariate logistic regression analysis, longer duration
of glucocorticoid treatment (OR, 1.12; 95% confidence
interval [CI], 1.03-1.22) and lower BMI SDS (OR, 0.42;
95% CI, 0.21-0.83) were associated with decreased LBMD
SDS. These findings suggest that prolonged glucocorticoid
use and reduction in BMI are risk factors for decreased
BMD in childhood cancer survivors. Anticipatory
follow-up and appropriate treatment are necessary,
especially for the patients with risk factors.
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